Juliet (Jules) Moritz

Juliet (Jules) Moritz is a pharmaceutical/biotechnology executive with over thirty years of experience in drug development across various settings.

Highly dedicated to improving patient engagement in clinical research and is recognized as a culturally sensitive global citizen.

Moritz holds a Doctor of Professional Studies in Bioethics with a focus on Health Education and Policy from Albany Medical College, a Master of Public Health in Public Health from Drexel University, and a Bachelor of Arts in Biology from the University of Pennsylvania.

She also completed a Professional Certificate in Genetics and Genomics from Stanford University.

Throughout her career, Moritz has held notable positions such as Senior Vice President at ERGOMED, Vice President at Strateos, Executive Vice President at Elligo Health Research, and Senior Vice President at Premier Research, among others.

Her expertise spans strategic solutions, patient centricity, project management, market development, and program strategy across various healthcare organizations.

Prior roles include leadership positions at Illingworth Research Group, Knopp Biosciences LLC, PPD, Inc., Theravance, and Wyeth Pharmaceuticals.

An experienced professional in the pharmaceutical and biotech industry with a strong focus on enhancing drug development and research operations.